The global bisphosphonates market, valued at USD 2.6 billion in 2025, is projected to grow at a compound annual growth rate (CAGR) of 3.8%, reaching USD 3.8 billion by 2035. Bisphosphonates, a class of drugs with high affinity for bone tissue, are primarily used to treat a range of bone-related conditions such as osteoporosis, myeloma, and bone metastases. As the aging population incr... https://industrytoday.co.uk/health_and_safety/bisphosphonates-market-poised-for-steady-growth-projected-to-reach-usd-38-billion-by-2035